The Center for Science in the Public Interest is urging federal authorities to require testing be done in accredited labs and not just to restrict that to the food importation process. It’s a laudable goal but one that might have unintended consequences,...
Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
The US Food and Drug Administration says it will move actively to prevent the worldwide trade in dietary ingredients, food ingredients and whole foods from being restricted because of misplaced coronavirus infection concerns.
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.